Skip to content

Clinical trials

Phase 4 Diabetes Mellitus trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 4 Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20075
20114
20121
20141
20152
20212
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status3
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center4
University Medical Center Groningen4
Amsterdam UMC, location VUmc3
Novo Nordisk A/S3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
GlaxoSmithKline2
Astellas Pharma Inc1
Carmen Dietvorst1
Eli Lilly and Company1
Keryx Biopharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus24
Diabetes Mellitus, Type 210
Diabetic Nephropathies4
Hypertension3
Albuminuria2
Diabetes Complications2
Proteinuria2
Renal Insufficiency, Chronic2
Diabetes Mellitus, Type 11
Diabetic Foot1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.